Amihai Rottenstreich | Maternal Fetal Medicine | Best Researcher Award Posted on 09/09/202410/09/2024 by ScienceFather Prof. Amihai Rottenstreich | Maternal Fetal Medicine | Best Researcher Award Maternal Fetal Medicine Specialist of Rockefeller University, United States. Dr. Amihai Rottenstreich is a distinguished researcher and clinician with a robust academic and professional background. He earned his B.Sc. and M.D. degrees summa cum laude from Technion – Israel Institute of Technology. His research experience spans prestigious institutions, including St Thomas’ Hospital and Rockefeller University, focusing on obstetric hematology and thrombosis. Dr. Rottenstreich has received multiple awards, such as the Betty Shane Scholarship Award and the Kochman Best Researcher Award, recognizing his impactful research. He has secured several research grants for innovative projects, like antiplatelet drugs and postpartum thromboprophylaxis. His active roles in professional societies and editorial boards, combined with his mentorship of PhD and Master’s students, highlight his commitment to advancing his field. Dr. Rottenstreich’s impressive achievements and contributions make him a strong candidate for the Research for Innovation Excellence Award. Profile ORCID Profile Education Amihai Rottenstreich, MD, has a distinguished educational background with a focus on medical sciences and clinical research. He earned his B.Sc. in Medical Sciences summa cum laude from Technion – Israel Institute of Technology in 2010, achieving a notable GPA of 95.5. He continued his studies at Technion, obtaining his Medical Doctor degree summa cum laude in 2013, with a GPA of 94.5. His thesis investigated the relationship between viral load of varicella zoster virus and the clinical progression of central nervous system infections. Following his medical education, Dr. Rottenstreich completed a rotating internship at Hadassah-Hebrew University Medical Center, Jerusalem, in 2014. He then pursued specialized training, including research fellowships at St Thomas’ Hospital in London and Rockefeller University in New York. His ongoing fellowship at the Clinical Scholars Program and Blood and Vascular Biology Laboratory further underscores his commitment to advancing medical research. Professional Experience Dr. Amihai Rottenstreich has a distinguished professional trajectory marked by extensive research and clinical experience. After completing his rotating internship at Hadassah-Hebrew University Medical Center, he specialized in hematology as a research fellow in the Coagulation Unit from 2016 to 2017. His residency in Obstetrics and Gynecology at the same institution spanned from 2017 to 2022. He further honed his expertise with a research fellowship in obstetric hematology at St Thomas’ Hospital in London in 2019, working under Prof. Beverly Hunt. Currently, Dr. Rottenstreich is engaged in a fellowship program at Rockefeller University and the Center for Maternal Fetal Medicine in New York, focusing on advanced research in maternal and fetal health. His roles have consistently integrated high-impact research with clinical practice, demonstrating his commitment to advancing medical science and improving patient care. Research Interest Dr. Amihai Rottenstreich’s research interests are primarily focused on obstetric hematology, thrombosis, and thrombophilia. His work explores the complex interactions between coagulation systems and pregnancy-related complications, such as antiphospholipid syndrome and preeclampsia. He investigates the molecular mechanisms underlying these conditions and their impact on maternal and fetal health. His research aims to improve diagnostic and therapeutic approaches for managing thrombotic disorders in pregnancy, including the use of antiplatelet drugs and thromboprophylaxis strategies. Additionally, Dr. Rottenstreich’s projects encompass the study of glycemic balance and its effects on pregnancy outcomes, as well as innovative models for evaluating treatment efficacy in tumor development. His work integrates clinical and laboratory research to advance understanding and improve patient care in obstetric and gynecological settings. Research Skills Amihai Rottenstreich, MD, exhibits exceptional research skills across a broad spectrum of medical and clinical fields. His expertise spans obstetric hematology, thrombosis, and reproductive health, as evidenced by his impactful research on varicella zoster virus and anticoagulant therapies. Dr. Rottenstreich’s proficiency in designing and conducting complex studies is highlighted by his successful research fellowships at prestigious institutions like St Thomas’ Hospital and Rockefeller University. He has secured multiple research grants, including significant funding for innovative projects on antiplatelet drugs and low-dose aspirin in preeclampsia prevention. His contributions to the academic community are further demonstrated through his roles as an ad hoc reviewer and editorial board member for numerous high-impact journals. Dr. Rottenstreich’s ability to mentor students and lead research projects underscores his strong analytical skills, methodological rigor, and commitment to advancing medical science through both clinical and laboratory research. Award and Recognition Amihai Rottenstreich, MD, has garnered numerous prestigious awards and recognitions throughout his career, underscoring his excellence in medical research and clinical practice. He achieved summa cum laude honors for both his B.Sc. and M.D. degrees from Technion – Israel Institute of Technology and has been consistently recognized for his academic excellence. Notable accolades include the Betty Shane Scholarship Award for research excellence, the Kochman Best Researcher Award from Hebrew University, and the Gendal Young Researcher Award. His research contributions have been further acknowledged with multiple best paper awards, including those from the Israeli Maternal & Fetal Medicine Annual Congress and the International Federation for the Surgery of Obesity and Metabolic Disorders European Chapter. Dr. Rottenstreich’s innovative work has also been supported by several significant research grants, including those from the Clinical Scholars Program at Rockefeller University and the Mirski Foundation. Conclusion Amihai Rottenstreich, MD, is a highly qualified candidate for the Research for Innovation Excellence Award. His strong academic background, significant research contributions, and active engagement in the academic community make him a standout nominee. Addressing areas for improvement, such as detailing the broader impact of his research and innovative projects, could further solidify his candidacy. His proven track record of excellence in research, awards, and grants demonstrates his potential for continued innovation and impact in his field. Publication Top Notes Placenta-Mediated Conditions: Past, Present, and Future Perspectives Authors: Amihai Rottenstreich Year: 2024 DOI: 10.3390/jcm13164631 Controversies and Clarifications Regarding the Role of Aspirin in Preeclampsia Prevention: A Focused Review Authors: Amihai Rottenstreich Year: 2024 DOI: 10.3390/jcm13154427
Dr. Amihai Rottenstreich is a distinguished researcher and clinician with a robust academic and professional background. He earned his B.Sc. and M.D. degrees summa cum laude from Technion – Israel Institute of Technology. His research experience spans prestigious institutions, including St Thomas’ Hospital and Rockefeller University, focusing on obstetric hematology and thrombosis. Dr. Rottenstreich has received multiple awards, such as the Betty Shane Scholarship Award and the Kochman Best Researcher Award, recognizing his impactful research. He has secured several research grants for innovative projects, like antiplatelet drugs and postpartum thromboprophylaxis. His active roles in professional societies and editorial boards, combined with his mentorship of PhD and Master’s students, highlight his commitment to advancing his field. Dr. Rottenstreich’s impressive achievements and contributions make him a strong candidate for the Research for Innovation Excellence Award. Profile ORCID Profile Education Amihai Rottenstreich, MD, has a distinguished educational background with a focus on medical sciences and clinical research. He earned his B.Sc. in Medical Sciences summa cum laude from Technion – Israel Institute of Technology in 2010, achieving a notable GPA of 95.5. He continued his studies at Technion, obtaining his Medical Doctor degree summa cum laude in 2013, with a GPA of 94.5. His thesis investigated the relationship between viral load of varicella zoster virus and the clinical progression of central nervous system infections. Following his medical education, Dr. Rottenstreich completed a rotating internship at Hadassah-Hebrew University Medical Center, Jerusalem, in 2014. He then pursued specialized training, including research fellowships at St Thomas’ Hospital in London and Rockefeller University in New York. His ongoing fellowship at the Clinical Scholars Program and Blood and Vascular Biology Laboratory further underscores his commitment to advancing medical research. Professional Experience Dr. Amihai Rottenstreich has a distinguished professional trajectory marked by extensive research and clinical experience. After completing his rotating internship at Hadassah-Hebrew University Medical Center, he specialized in hematology as a research fellow in the Coagulation Unit from 2016 to 2017. His residency in Obstetrics and Gynecology at the same institution spanned from 2017 to 2022. He further honed his expertise with a research fellowship in obstetric hematology at St Thomas’ Hospital in London in 2019, working under Prof. Beverly Hunt. Currently, Dr. Rottenstreich is engaged in a fellowship program at Rockefeller University and the Center for Maternal Fetal Medicine in New York, focusing on advanced research in maternal and fetal health. His roles have consistently integrated high-impact research with clinical practice, demonstrating his commitment to advancing medical science and improving patient care. Research Interest Dr. Amihai Rottenstreich’s research interests are primarily focused on obstetric hematology, thrombosis, and thrombophilia. His work explores the complex interactions between coagulation systems and pregnancy-related complications, such as antiphospholipid syndrome and preeclampsia. He investigates the molecular mechanisms underlying these conditions and their impact on maternal and fetal health. His research aims to improve diagnostic and therapeutic approaches for managing thrombotic disorders in pregnancy, including the use of antiplatelet drugs and thromboprophylaxis strategies. Additionally, Dr. Rottenstreich’s projects encompass the study of glycemic balance and its effects on pregnancy outcomes, as well as innovative models for evaluating treatment efficacy in tumor development. His work integrates clinical and laboratory research to advance understanding and improve patient care in obstetric and gynecological settings. Research Skills Amihai Rottenstreich, MD, exhibits exceptional research skills across a broad spectrum of medical and clinical fields. His expertise spans obstetric hematology, thrombosis, and reproductive health, as evidenced by his impactful research on varicella zoster virus and anticoagulant therapies. Dr. Rottenstreich’s proficiency in designing and conducting complex studies is highlighted by his successful research fellowships at prestigious institutions like St Thomas’ Hospital and Rockefeller University. He has secured multiple research grants, including significant funding for innovative projects on antiplatelet drugs and low-dose aspirin in preeclampsia prevention. His contributions to the academic community are further demonstrated through his roles as an ad hoc reviewer and editorial board member for numerous high-impact journals. Dr. Rottenstreich’s ability to mentor students and lead research projects underscores his strong analytical skills, methodological rigor, and commitment to advancing medical science through both clinical and laboratory research. Award and Recognition Amihai Rottenstreich, MD, has garnered numerous prestigious awards and recognitions throughout his career, underscoring his excellence in medical research and clinical practice. He achieved summa cum laude honors for both his B.Sc. and M.D. degrees from Technion – Israel Institute of Technology and has been consistently recognized for his academic excellence. Notable accolades include the Betty Shane Scholarship Award for research excellence, the Kochman Best Researcher Award from Hebrew University, and the Gendal Young Researcher Award. His research contributions have been further acknowledged with multiple best paper awards, including those from the Israeli Maternal & Fetal Medicine Annual Congress and the International Federation for the Surgery of Obesity and Metabolic Disorders European Chapter. Dr. Rottenstreich’s innovative work has also been supported by several significant research grants, including those from the Clinical Scholars Program at Rockefeller University and the Mirski Foundation. Conclusion Amihai Rottenstreich, MD, is a highly qualified candidate for the Research for Innovation Excellence Award. His strong academic background, significant research contributions, and active engagement in the academic community make him a standout nominee. Addressing areas for improvement, such as detailing the broader impact of his research and innovative projects, could further solidify his candidacy. His proven track record of excellence in research, awards, and grants demonstrates his potential for continued innovation and impact in his field. Publication Top Notes Placenta-Mediated Conditions: Past, Present, and Future Perspectives Authors: Amihai Rottenstreich Year: 2024 DOI: 10.3390/jcm13164631 Controversies and Clarifications Regarding the Role of Aspirin in Preeclampsia Prevention: A Focused Review Authors: Amihai Rottenstreich Year: 2024 DOI: 10.3390/jcm13154427
Amihai Rottenstreich, MD, has a distinguished educational background with a focus on medical sciences and clinical research. He earned his B.Sc. in Medical Sciences summa cum laude from Technion – Israel Institute of Technology in 2010, achieving a notable GPA of 95.5. He continued his studies at Technion, obtaining his Medical Doctor degree summa cum laude in 2013, with a GPA of 94.5. His thesis investigated the relationship between viral load of varicella zoster virus and the clinical progression of central nervous system infections. Following his medical education, Dr. Rottenstreich completed a rotating internship at Hadassah-Hebrew University Medical Center, Jerusalem, in 2014. He then pursued specialized training, including research fellowships at St Thomas’ Hospital in London and Rockefeller University in New York. His ongoing fellowship at the Clinical Scholars Program and Blood and Vascular Biology Laboratory further underscores his commitment to advancing medical research.
Dr. Amihai Rottenstreich has a distinguished professional trajectory marked by extensive research and clinical experience. After completing his rotating internship at Hadassah-Hebrew University Medical Center, he specialized in hematology as a research fellow in the Coagulation Unit from 2016 to 2017. His residency in Obstetrics and Gynecology at the same institution spanned from 2017 to 2022. He further honed his expertise with a research fellowship in obstetric hematology at St Thomas’ Hospital in London in 2019, working under Prof. Beverly Hunt. Currently, Dr. Rottenstreich is engaged in a fellowship program at Rockefeller University and the Center for Maternal Fetal Medicine in New York, focusing on advanced research in maternal and fetal health. His roles have consistently integrated high-impact research with clinical practice, demonstrating his commitment to advancing medical science and improving patient care. Research Interest Dr. Amihai Rottenstreich’s research interests are primarily focused on obstetric hematology, thrombosis, and thrombophilia. His work explores the complex interactions between coagulation systems and pregnancy-related complications, such as antiphospholipid syndrome and preeclampsia. He investigates the molecular mechanisms underlying these conditions and their impact on maternal and fetal health. His research aims to improve diagnostic and therapeutic approaches for managing thrombotic disorders in pregnancy, including the use of antiplatelet drugs and thromboprophylaxis strategies. Additionally, Dr. Rottenstreich’s projects encompass the study of glycemic balance and its effects on pregnancy outcomes, as well as innovative models for evaluating treatment efficacy in tumor development. His work integrates clinical and laboratory research to advance understanding and improve patient care in obstetric and gynecological settings. Research Skills Amihai Rottenstreich, MD, exhibits exceptional research skills across a broad spectrum of medical and clinical fields. His expertise spans obstetric hematology, thrombosis, and reproductive health, as evidenced by his impactful research on varicella zoster virus and anticoagulant therapies. Dr. Rottenstreich’s proficiency in designing and conducting complex studies is highlighted by his successful research fellowships at prestigious institutions like St Thomas’ Hospital and Rockefeller University. He has secured multiple research grants, including significant funding for innovative projects on antiplatelet drugs and low-dose aspirin in preeclampsia prevention. His contributions to the academic community are further demonstrated through his roles as an ad hoc reviewer and editorial board member for numerous high-impact journals. Dr. Rottenstreich’s ability to mentor students and lead research projects underscores his strong analytical skills, methodological rigor, and commitment to advancing medical science through both clinical and laboratory research. Award and Recognition Amihai Rottenstreich, MD, has garnered numerous prestigious awards and recognitions throughout his career, underscoring his excellence in medical research and clinical practice. He achieved summa cum laude honors for both his B.Sc. and M.D. degrees from Technion – Israel Institute of Technology and has been consistently recognized for his academic excellence. Notable accolades include the Betty Shane Scholarship Award for research excellence, the Kochman Best Researcher Award from Hebrew University, and the Gendal Young Researcher Award. His research contributions have been further acknowledged with multiple best paper awards, including those from the Israeli Maternal & Fetal Medicine Annual Congress and the International Federation for the Surgery of Obesity and Metabolic Disorders European Chapter. Dr. Rottenstreich’s innovative work has also been supported by several significant research grants, including those from the Clinical Scholars Program at Rockefeller University and the Mirski Foundation. Conclusion Amihai Rottenstreich, MD, is a highly qualified candidate for the Research for Innovation Excellence Award. His strong academic background, significant research contributions, and active engagement in the academic community make him a standout nominee. Addressing areas for improvement, such as detailing the broader impact of his research and innovative projects, could further solidify his candidacy. His proven track record of excellence in research, awards, and grants demonstrates his potential for continued innovation and impact in his field. Publication Top Notes Placenta-Mediated Conditions: Past, Present, and Future Perspectives Authors: Amihai Rottenstreich Year: 2024 DOI: 10.3390/jcm13164631 Controversies and Clarifications Regarding the Role of Aspirin in Preeclampsia Prevention: A Focused Review Authors: Amihai Rottenstreich Year: 2024 DOI: 10.3390/jcm13154427